Market revenue in 2023 | USD 775.8 million |
Market revenue in 2030 | USD 1,310.5 million |
Growth rate | 7.8% (CAGR from 2023 to 2030) |
Largest segment | Molecular diagnostics |
Fastest growing segment | Immunoassays |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunoassays, Hematology and Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Flow Cytometry, Mass Spectroscopy |
Key market players worldwide | Quest Diagnostics Inc, 23andMe Holding Co Class A, Abbott Laboratories, Guardant Health Inc, NeoGenomics, Siemens Healthineers AG ADR, Qiagen NV, Illumina Inc, Roche Holding AG ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to laboratory developed tests market will help companies and investors design strategic landscapes.
Molecular diagnostics was the largest segment with a revenue share of 26.32% in 2023. Horizon Databook has segmented the France laboratory developed tests market based on immunoassays, hematology and coagulation, molecular diagnostics, microbiology, clinical chemistry, histology/cytology, flow cytometry, mass spectroscopy covering the revenue growth of each sub-segment from 2018 to 2030.
There have been several advancements in the field of LDTs in France. The healthcare system emphasizes on the use of innovative technologies to improve patient outcomes, which has boosted the demand for LDTs in the country.
Companies like bioMérieux, Novacyt, and others, have developed LDTs that deliver fast & accurate results, making it possible for healthcare providers to make rapid diagnoses and provide proper treatment.
Furthermore, LDTs in France are utilizing advanced technologies such as genomic sequencing and molecular diagnostics to deliver more accurate & reliable results. These technologies are enhancing the detection and diagnosis of various diseases, including cancer.
Horizon Databook provides a detailed overview of country-level data and insights on the France laboratory developed tests market , including forecasts for subscribers. This country databook contains high-level insights into France laboratory developed tests market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account